Sign In
Buy DYAI
$1.05
-0.0200 (-1.87%)
At Close: Jul 31, 2026
Dyadic to Present at Upcoming Industry and Investor Events in September
08:30am, Thursday, 08'th Sep 2022
JUPITER, Fla., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbia
Dyadic International, Inc. (DYAI) CEO Mark Emalfarb on Q2 2022 Results - Earnings Call Transcript
10:59pm, Wednesday, 10'th Aug 2022
Dyadic International, Inc. (NASDAQ:DYAI ) Q2 2022 Earnings Conference Call August 10, 2022 5:00 PM ET Corporate Participants Ping Rawson - Chief Financial Officer Mark Emalfarb - President & Chief Exe
Dyadic to Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022
08:30pm, Wednesday, 27'th Jul 2022 GlobeNewswire Inc.
JUPITER, Fla., July 27, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused
Dyadic to Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022
04:30pm, Wednesday, 27'th Jul 2022
JUPITER, Fla., July 27, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused o
Dyadic to Participate in Bio-Manufacturing Innovation Summit and NIIMBL National Meeting
12:30pm, Tuesday, 05'th Jul 2022 GlobeNewswire Inc.
JUPITER, Fla., July 05, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying
Dyadic to Participate in Three Upcoming Industry Events
01:09pm, Thursday, 09'th Jun 2022 GlobeNewswire Inc.
JUPITER, Fla., June 09, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying
Dyadic to Present at 2022 Jefferies Healthcare Conference
01:27pm, Thursday, 02'nd Jun 2022 GlobeNewswire Inc.
JUPITER, Fla., June 02, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying
Dyadic to Present at 2022 Jefferies Healthcare Conference
09:27am, Thursday, 02'nd Jun 2022
JUPITER, Fla., June 02, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying a
Dyadic to Present at H.C. Wainwright Global Investment Conference
12:30pm, Friday, 20'th May 2022 GlobeNewswire Inc.
JUPITER, Fla., May 20, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology company focused on further improving, applying a
Dyadic to Present at H.C. Wainwright Global Investment Conference
08:30am, Friday, 20'th May 2022
JUPITER, Fla., May 20, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology company focused on further improving, applying and
Dyadic International, Inc. (DYAI) CEO Mark Emalfarb on Q1 2022 Results - Earnings Call Transcript
11:16pm, Thursday, 12'th May 2022
Dyadic International, Inc. (NASDAQ:DYAI ) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants Ping Rawson - Chief Financial Officer Mark Emalfarb - President & Chief Executiv
Dyadic to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
08:30pm, Thursday, 28'th Apr 2022 GlobeNewswire Inc.
JUPITER, Fla., April 28, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focuse
Epygen Biotech Announces Funding from India Government for Development of a COVID-19 Vaccine Using Dyadic’s Licensed C1 Protein Production Platform
12:52pm, Wednesday, 13'th Apr 2022 GlobeNewswire Inc.
JUPITER, Fla., April 13, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company anno
Dyadic International to Present at Upcoming Scientific Medical Meetings
12:30pm, Monday, 04'th Apr 2022 GlobeNewswire Inc.
JUPITER, Fla., April 04, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology company focused on further improving, applying
Dyadic International to Present at Upcoming Scientific Medical Meetings
08:30am, Monday, 04'th Apr 2022
JUPITER, Fla., April 04, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology company focused on further improving, applying a
